Our medical, nursing and allied health clinicians are increasingly involved in research to improve the care of our patients. This is reflected in the breadth of our research publications.
Wnt is necessary for mesenchymal to epithelial transition in colorectal cancer cells
Schwab, RHM; Amin, N; Flanagan, DJ; Johanson, TM; Phesse, TJ; Vincan, E
(2018), Dev. Dyn., 521-530
DOI: 10.1002/dvdy.24527
The First Isolation and Whole Genome Sequencing of Murray Valley Encephalitis Virus from Cerebrospinal Fluid of a Patient with Encephalitis
Russell, JS; Caly, L; Kostecki, R; McGuinness, SL; Carter, G; Bulach, D; Seemann, T; Stinear, TP; Baird, R; Catton, M; Druce, J
(2018), Viruses-Basel
DOI: 10.3390/v10060319
The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and Reversed
Rezaei, SD; Lu, HK; Chang, JJ; Rhodes, A; Lewin, SR; Cameron, PU
(2018), J. Virol.
DOI: 10.1128/JVI.02225-17
Viral regulation of host cell biology by hijacking of the nucleolar DNA-damage response
Rawlinson, SM; Zhao, TY; Rozario, AM; Rootes, CL; McMillan, PJ; Purcell, AW; Woon, A; Marsh, GA; Lieu, KG; Wang, LF; Netter, HJ; Bell, TDM; Stewart, CR; Moseley, GW
(2018), Nat. Commun.
The effect of antiretroviral intensification with dolutegravir on residual virus replication in HIV-infected individuals: a randomised, placebo-controlled, double-blind trial
Rasmussen, TA; McMahon, JH; Chang, JJ; Audsley, J; Rhodes, A; Tennakoon, S; Dantanarayana, A; Spelman, T; Schmidt, T; Kent, SJ; Morcilla, V; Palmer, S; Elliott, JH; Lewin, SR
(2018), Lancet HIV, E221-E230
Designing group dose-response studies in the presence of transmission
Price, DJ; Bean, NG; Ross, JV; Tuke, J
(2018), Math. Biosci., 62-78
An induced natural selection heuristic for finding optimal Bayesian experimental designs
Price, DJ; Bean, NG; Ross, JV; Tuke, J
(2018), Comput. Stat. Data Anal., 112-124
Perceptions of HIV cure research among people living with HIV in Australia
Power, J; Westle, A; Dowsett, GW; Lucke, J; Tucker, JD; Sugarman, J; Lewin, SR; Hill, S; Brown, G; Wallace, J; Richmond, J
(2018), PLoS One
HIV-1 subtype diversity, transmitted drug resistance and phylogenetics in Australia
Pinto, AN; Hawke, K; Castley, A; Chibo, D; Di Giallonardo, F; Cooper, C; Sawleshwarkar, S; Kelleher, A; Dwyer, DE
(2018), Future Virol., 575-584
Selection of multi-drug resistant influenza A and B viruses under zanamivir pressure and their replication fitness in ferrets
Oh, DY; Panozzo, J; Vitesnik, S; Farrukee, R; Piedrafita, D; Mosse, J; Hurt, AC
(2018), Antivir. Ther., 295-306
DOI: 10.3851/IMP3135
Epidemic forecasts as a tool for public health: interpretation and (re)calibration
Moss, R; Fielding, JE; Franklin, LJ; Stephens, N; McVernon, J; Dawson, P; Mccaw, JM
(2018), Aust. N. Z. Publ. Health, 69-76
Animal models used to assess influenza antivirals
Mifsud, EJ; Tai, CMK; Hurt, AC
(2018), Expert. Opin. Drug Discov., 1131-1139
Susceptibility of Brazilian influenza A(H1N1)pdm09 viruses to neuraminidase inhibitors in the 2014-2016 seasons: Identification of strains bearing mutations associated with reduced inhibition profile
Matos, AR; Resende, PC; Miranda, MD; Garcia, CC; Caetano, BC; Lopes, JCO; Debur, MC; Cury, ALF; Vianna, LA; Lima, MC; Schirmer, M; Gubareva, L; Hurt, AC; Brown, DW; Siqueira, MM
(2018), Antiviral Res., 35-43
Cultural and linguistic diversity of people living with chronic hepatitis B in 2011-2016: changing migration, shifting epidemiology
MacLachlan, JH; Cowie, BC
(2018), Aust. N. Z. Publ. Health, 441-443
Mapping progress in chronic hepatitis B: geographic variation in prevalence, diagnosis, monitoring and treatment, 2013-15
MacLachlan, J; Allard, N; Carville, K; Haynes, K; Cowie, B
(2018), Aust. N. Z. Publ. Health, 62-68
Measles control in Australia - threats, opportunities and future needs
MacIntyre, CR; Kpozehouen, E; Kunasekaran, M; Harriman, K; Conaty, S; Rosewell, A; Druce, J; Martin, N; Heywood, AE; Gidding, HF; Wood, J; Nicholl, S
(2018), Vaccine, 4393-4398
Epidemiology of Buruli Ulcer Infections, Victoria, Australia, 2011-2016
Loftus, MJ; Tay, EL; Globan, M; Lavender, CJ; Crouch, SR; Johnson, PDR; Fyfe, JAM
(2018), Emerg. Infect. Dis, 1988-1997
Enrichment of gut-derived Fusobacterium is associated with suboptimal immune recovery in HIV-infected individuals
Lee, SC; Chua, LL; Yap, SH; Khang, TF; Leng, CY; Azwa, RIR; Lewin, SR; Kamarulzaman, A; Woo, YL; Lim, YAL; Loke, P; Rajasuriar, R
(2018), Sci Rep
Neuraminidase inhibitor resistance in influenza: a clinical perspective
Lee, N; Hurt, AC
(2018), Curr. Opin. Infect. Dis., 520-526
The hepatitis B epidemic and the urgent need for cure preparedness
Lazarus, JV; Block, T; Brechot, C; Kramvis, A; Miller, V; Ninburg, M; Penicaud, C; Protzer, U; Razavi, H; Thomas, LA; Wallace, J; Cowie, BC
(2018), Nat. Rev. Gastroenterol. Hepatol., 517-518
Evidence for Viral Interference and Cross-reactive Protective Immunity Between Influenza B Virus Lineages
Laurie, KL; Horman, W; Carolan, LA; Chan, KF; Layton, D; Bean, A; Vijaykrishna, D; Reading, PC; Mccaw, JM; Barr, IG
(2018), J. Infect. Dis., 548-559
The role of human rhinovirus (HRV) species on asthma exacerbation severity in children and adolescents
Lambert, KA; Prendergast, LA; Dharmage, SC; Tang, M; O'Sullivan, M; Tran, T; Druce, J; Bardin, P; Abramson, MJ; Erbas, B
(2018), J. Asthma, 596-602
Steps to solving the infant biometric problem with ridge-based biometrics
Kotzerke, J; Davis, SA; McVernon, J; Horadam, KJ
(2018), IET Biom., 567-572
Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model
Korenkov, DA; Laurie, KL; Reading, PC; Carolan, LA; Chan, KF; Isakova-Sivak, II; Smolonogina, TA; Subbarao, K; Barr, IG; Villanueva, J; Shcherbik, S; Bousse, T; Rudenko, LG
(2018), Infect. Genet. Evol., 95-104
In memoriam: Professor David Cooper (1949 to 2018)
Kippax, S; Mayer, KH; Sohn, A; Bekker, LG; Pozniak, A; Beyrer, C; Lewin, SR; Ryan, O; Phanuphak, P; Kirby, M
(2018), J. Int. AIDS Soc.
DOI: 10.1002/jia2.25152
Getting the Kill into Shock and Kill: Strategies to Eliminate Latent HIV
Kim, Y; Anderson, JL; Lewin, SR
(2018), Cell Host Microbe, 14-26
HIV latency reversing agents act through Tat post translational modifications
Khoury, G; Mota, TM; Li, S; Tumpach, C; Lee, MY; Jacobson, J; Harty, L; Anderson, JL; Lewin, SR; Purcell, DFJ
(2018), Retrovirology
Surgery for Buruli ulcer in the antibiotic era
Johnson, PDR
(2018), Lancet Infect. Dis., 588-589
Epidemiology and phylogenetic analysis of hepatitis D virus infection in Australia
Jackson, K; MacLachlan, J; Cowie, B; Locarnini, S; Bowden, S; Higgins, N; Karapanagiotidis, T; Nicholson, S; Littlejohn, M
(2018), Intern. Med. J., 1308-1317
DOI: 10.1111/imj.13967